United Services Automobile Association’s Navidea Biopharmaceuticals NAVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-1,315
Closed -$4K – 2314
2019
Q1
$4K Hold
1,315
– – ﹤0.01% 2256
2018
Q4
$3K Hold
1,315
– – ﹤0.01% 2235
2018
Q3
$6K Hold
1,315
– – ﹤0.01% 2308
2018
Q2
$6K Hold
1,315
– – ﹤0.01% 2295
2018
Q1
$9K Buy
+1,315
New +$9.8K ﹤0.01% 2264

Other funds holding NAVB

United Services Automobile Association's NAVB Position: Q2 2019 in Review

United Services Automobile Association sold out of Navidea Biopharmaceuticals (NAVB) in Q2 2019, closing a stake of 1,315 shares — an estimated $4K sold.

United Services Automobile Association first reported a position in NAVB in Q1 2018 and held it in 5 quarters. The position peaked at $9K in Q1 2018. 27 funds tracked by Wall St. Rank hold NAVB as of Q2 2019.

  • United Services Automobile Association reported no remaining Navidea Biopharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • United Services Automobile Association sold 1,315 Navidea Biopharmaceuticals shares in Q2 2019, an estimated $4K.
  • United Services Automobile Association first reported a position in Navidea Biopharmaceuticals in Q1 2018 and held it in 5 quarters.
  • United Services Automobile Association's Navidea Biopharmaceuticals position peaked at $9K in Q1 2018.
  • 27 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals as of Q2 2019.

Based on United Services Automobile Association's 13F filing for Q2 2019, filed 16 Aug 2019.